“Recent hospital consolidation is about two factors: financial sustainability and strategic transformation,” one expert tells us.

Brittany Holloway-Brown, Photos: Adobe Stock
If it seems like there’s been a healthy number of hospital mergers and acquisitions this year, you’re not imagining it.
An October report from healthcare consultancy Kaufman Hall, a Vizient company, suggested that 2026 may be the biggest year for hospital M&A deals since 2019. There have been 56 transactions up through Q3, according to the report, compared to full-year totals of 46 in 2025, 72 in 2024, and 65 in 2023.
Some deals you may recall from recent (shameless plug) Signed and Scrubbed roundups include: Chicago’s Rush University System for Health’s plans to merge with the nearby Evanston-based Endeavor Health, news of NYC Health + Hospitals acquiring Brooklyn-based Maimonides Health, and Florida’s AdventHealth joint venture announcement with Utah’s Intermountain Health.
There are pros and cons for both the acquiring and acquired hospitals. For the hospitals conducting the deals, they’ll take on any debt from the smaller entities but also get the potential benefit of financial growth. Hospitals being acquired may have been at risk of closing, especially the smaller independent ones, so being integrated into bigger systems can keep them open—but may also raise costs for patients, according to a 2022 report from the nonprofit Rand.
Even still, hospitals remain under financial stress, according to a September Kaufman Hall report that found 1,300+ hospitals had a YTD median operating margin of 1.1% when adjusted for corporate allocations and intercompany transfers, down from 2.5% in August, largely attributed to issues surrounding payer mix and inflation. Experts told Healthcare Brew dealmaking is how many systems see their way into healthier margins and a more stable future.
“Recent hospital consolidation is about two factors: financial sustainability and strategic transformation,” Dan Farrell, PwC’s US health services deals leader, told us.
While we’re years out from the height of the Covid-19 pandemic, hospitals are still facing a lot of the same challenges, like supply chain and labor cost pressures.
The crux of the issue is that hospitals—big and small, independent and system-affiliated—are looking to find more sustainable operating models, Farrell said.
“For challenged hospitals, that means typically needing capital [and] operational support,” he said. “For the stronger systems, they’re typically seeking capabilities, network expansion, future positioning, or even competitive defensive positions.”
Bigger health systems typically mean a bigger market share and purchasing power, which can help hospitals negotiate higher reimbursement rates from commercial health plans, according to the Association of American Medical Colleges. Systems can also consolidate costs for items like technology or recruitment. For example, if a hospital implements an AI scribe, it only needs one solution for all its hospitals.
M&A also occasionally allows systems to expand their footprints across different states. (Think AdventHealth and Intermountain Health mentioned above.) This strategy prevents reliance on one market or policy landscape, experts said.
“The local market economic risk and other potential downsides…is then spread, and you’re able to preserve the access to resources in both communities,” Neil Rao, senior partner at consultancy McKinsey & Company, told us.
As a result, health systems can get access to wider patient pools. Hospitals often run clinical trials and are looking to be the “most credible partner” with the life science industry, Rao said. Having more access to potential trial participants can be attractive to pharma companies because testing products on diverse patient groups can lead to more comprehensive results. Plus, more patients means systems can potentially stand up more specialized care that can bring in significant revenue, like programs for novel gene and cell therapies or organ transplantation.
“Unless you actually have a large enough patient cohort, it’s hard to run those programs at scale,” Rao said.
Farrell and Rao predicted M&A to continue strong through the end of the year and into 2027, mostly because the existing cost pressures aren’t going anywhere anytime soon.
Though they also cautioned that M&A can come with its own set of challenges that hospitals and patients need to look out for. Getting bigger often “stretches management’s bandwidth,” for example, Rao said.
“Scale typically creates opportunity, but it doesn’t always automatically create value,” Farrell said.
Consolidation has also been tied to service closures at acquired hospitals, which could leave patients without care: A 2023 JAMA Pediatrics research letter found that merging with a hospital system was associated with inpatient pediatric service loss at general and pediatric hospitals within five years of a deal.
It’s also linked to healthcare cost increases because it can reduce market competition. Costs are already a major problem in US healthcare (duh) as premiums continue to rise and patients continue to find care unaffordable.
“It’s never easier to get bigger. Being bigger always comes with a set of complex challenges,” Farrell said.